Semi-Annual Report
Euro-obbligazioni: Teva Pharmaceutical Industries, 6.15% 1feb2036, USD (US88163VAD10)
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Mo rgad Sta n I ey
Asian Bond Market News Hong Kong – BondEvalue
Our Life Sciences and Healthcare sector focus
Unrest Makes Company Debt the New Emerging-Market Safety Bet - Bloomberg
Teva (circa 20 bond in Usd, Eur, Chf) 2.8% 2023 US88167AAD37, 3.15% 2026 US88167AAE10, 6.15% 2036 US88163VAD10 | Page 10 | Quelli Che Investono
Middle East USD Bonds - BondEvalue
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Teva (circa 20 bond in Usd, Eur, Chf) 2.8% 2023 US88167AAD37, 3.15% 2026 US88167AAE10, 6.15% 2036 US88163VAD10 | Page 22 | Quelli Che Investono
TNIBX - T. Rowe Price International Bond Fund (USD Hedged) - Portfolio Holdings, AUM (13F, 13G)
US Corporate IG Bonds Fell Today, While High Yield Rose On Tighter Cash Spreads | ϕpost: News & Analyses of Capital Markets
Teva (circa 20 bond in Usd, Eur, Chf) 2.8% 2023 US88167AAD37, 3.15% 2026 US88167AAE10, 6.15% 2036 US88163VAD10 | Page 22 | Quelli Che Investono
Global Bond Fund - HSBC Bermuda
Form 10-K
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Teva Pharma Trends Lower Ahead Of A Key Shareholder Meeting This Week (NYSE: TEVA) | Seeking Alpha
Teva (circa 20 bond in Usd, Eur, Chf) 2.8% 2023 US88167AAD37, 3.15% 2026 US88167AAE10, 6.15% 2036 US88163VAD10 | Page 8 | Quelli Che Investono
USD Bonds Rise On Lower Rates, Stable Spreads | ϕpost: News & Analyses of Capital Markets
Prospectus
